Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 234-679-1 | CAS number: 12023-27-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 17 September 2000 - 2 October 2000
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 000
- Report date:
- 2000
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Version / remarks:
- 1997
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.12 (Mutagenicity - In Vivo Mammalian Erythrocyte Micronucleus Test)
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- mammalian erythrocyte micronucleus test
Test material
- Reference substance name:
- Diiron titanium pentaoxide
- EC Number:
- 234-679-1
- EC Name:
- Diiron titanium pentaoxide
- Cas Number:
- 12023-27-7
- Molecular formula:
- Fe2O5Ti
- IUPAC Name:
- titanium(4+) diiron(3+) pentaoxidandiide
- Test material form:
- solid: particulate/powder
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Remarks:
- HsdCpb:WU
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Harlan Winkelmann GmbH, Wistar rats
- Age at study initiation: 8-10 weeks
- Weight at study initiation: 264 - 299 g
- Housing: individually in Makrolon cages type 3
- Diet: ad libitum, Standard Diet from Eberle Nafag AG, Gossau, Switzerland
- Water: ad libitum, tap water
- Acclimation period: at least 7 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 23 - 23.5
- Humidity (%): 57 - 62
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- 0.25% aqueous Methocel K4M Premium.
- Details on exposure:
- PREPARATION OF DOSING SOLUTIONS:
The test material group was dosed once with a limit dose of 2000 mg/kg bw.
Dosing volume: 10 mL/kg bw
Rats of the control group received the vehicle only. - Duration of treatment / exposure:
- The control and positive control were killed 24 hours after treatment.
The two test material groups were killed 24 and 48 hours after treatment. - Frequency of treatment:
- Single oral administration.
Doses / concentrations
- Dose / conc.:
- 2 000 mg/kg bw (total dose)
- No. of animals per sex per dose:
- 5 males /vehicle control group
5 males/ positive control group
10 males/ test material group - Control animals:
- yes, concurrent vehicle
- Positive control(s):
- The animals of the positive control were orally treated with cyclophosphamide at a dose of 16.5 mg/kg bw.
Examinations
- Tissues and cell types examined:
- Bone marrow
- Details of tissue and slide preparation:
- CRITERIA FOR DOSE SELECTION:
The highest dose given in the present study was selected to produce signs of toxicity but no mortality. Since the internationally valid guidelines recommend a maximum dose of 2000 mg/kg bw for this assay, 6 male and 6 female rats were treated orally with 2000 mg test item in preliminary range-finding experiments. No toxic effects were seen. For this reason, the dose of 2000 mg/kg body weight was selected as the highest, limit dose for male rats only in the main study of this investigation. The rats of the negative control group were treated orally with 10 mL of a 0.25 % aqueous MethocelR K4M premium solution. Animals of the positive control group received an oral dose of 16.5 mg cyclophosphamide/kg body weight With this dose a statistically significant increase in the number of polychromatic erythrocytes with micronuclei, as compared to the negative control, was to be expected.
TREATMENT AND SAMPLING TIMES
The control and positive control were killed 24 hours after treatment. The two test material groups were killed 24 and 48 hours after treatment.
DETAILS OF SLIDE PREPARATION
Immediately after the rats had been killed, one femur of each animal was dissected and cleaned from adherent muscles. The epiphyses were cut off and bone marrow cells were flushed out with fetal calf serum using a syringe, and suspended in the serum. This suspension was filtered through cellulose and centrifuged for 5 min at 150 x g. The sediment was resuspended in fetal calf serum and bone marrow smears were prepared from the resulting cell suspension. After 3 hours of drying, the slides were stained using Giemsa's solution with Weise buffer solution and mounted in Entellan.
METHOD OF ANALYSIS
A total of 2000 polychromatic erythrocytes per animal were scored for micronuclei using Zeiss light microscopes with plane optics (magnification: 1250x). Round particles with about 1/20 - 1/5 the diameter of an erythrocyte that stained violet, like nucleic
material, were scored as micronuclei. They were differentiated from granules by thorough examination at different optical levels. Only erythrocytes with a distinct bluish touch were evaluated as polychromatic. For determination of the quotient of normochromatic to polychromatic erythrocytes, both erythrocyte stages were screened for micronuclei and counted separately up to a total of 1000 erythrocytes per animal. Then counting was limited to polychromatic erythrocytes. - Evaluation criteria:
- A total of 2000 polychromatic erythrocytes (PCE) per animal were scored for micronuclei.
A positive effect in this test system is defined by the occurence of mean micronucleated PCEwhich are statistically significantly higher than those of the actual negative control, taking into account the historical negative controls of the laboratory. - Statistics:
- Exact Mann-Whitney-test.
Results and discussion
Test results
- Key result
- Sex:
- male
- Genotoxicity:
- negative
- Toxicity:
- no effects
- Vehicle controls validity:
- valid
- Negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- RESULTS OF DEFINITIVE STUDY
No clinical findings were onserved in treated animals. No relevant treatment-related decrease in body weight was observed.
No statistically significant or biologically relevant increase in the number of polychromatic erythrocytes with micronuclei (MN-PCE) was observed. For the number of normochromatic cells with micronuclei, calculated per 1000 normochromatic erythrocytes by means of the above mentioned quotient, no increase was observed.
Quotient normochromatic : polychromatic erythrocytes:
No relevant treatment-related increase was observed for the test item
Any other information on results incl. tables
Table 1: Results
Test material |
Dose |
Preparation |
MN-PCE [‰]a |
Solvent |
— |
24 |
0.40 |
Test item |
2000 |
24 |
0.40 |
Test item |
2000 |
48 |
0.80 |
Cyclophosphamide |
16.5 |
24 |
16.5* |
a:
Mean numbers of polychromatic erythrocytes with micronuclei per 1000 PCE
*: Statistically significant (p<0.01)
Applicant's summary and conclusion
- Conclusions:
- The test material was not mutagenic in the micronucleus assay in male rats under conditions where the positive control exerted potent mutagenic effects.
- Executive summary:
The test item was tested in an in vivo micronucleus assay in the rat. The test item was administered once orally by gavage to 10 male rats at the limit dose of 2000 mg/kg bw. A control group (5 animals) received the vehicle (0.25% aqueous Methocel®K4M premium) only. Cyclophosphamide was used as the positive substance (5 animals). Bone marrow smears were prepared from one femur of each animal and stained with Giemsa’s solution. For the test material group, preparation took place at two different times, i.e. 24 and 48 hours after administration of the test material. For the positive and negative control groups, the preparation time was 24 hours after start of the treatment. The number of polychromatic erythrocytes with micronuclei per 2000 polychromatic erythrocytes per animal was determined. The positive control showed the expected significant increase in the number of polychromatic erythrocytes with micronuclei. No statistically significant or biologically relevant increase in the number of polychromatic erythrocytes with micronuclei was observed in any of the pigment-treated groups. In conclusion, the test pigment item was not mutagenic in the micronucleus test in male rats under conditions of this study.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.